No Data
No Data
Mdxhealth S.A. Reports Strong Revenue Growth in Earnings Call
William Blair Maintains MDxHealth(MDXH.US) With Buy Rating
TD Cowen Maintains MDxHealth(MDXH.US) With Buy Rating, Maintains Target Price $7
MDxHealth: Strong Growth and Attractive Valuation Drive Buy Rating
Earnings Call Summary | MDxHealth(MDXH.US) Q4 2024 Earnings Conference
MDxHealth Reports Q4 EPS (14c) Vs. (39c) Last Year